Bico InstantScreen
This article was originally published in The Gray Sheet
Executive Summary
Rapid HIV diagnostic test will be marketed worldwide under an exclusive agreement with the German-American Institute for Applied Biomedical Research (GAIFAR), which manufactures the product. Preliminary data on the 30-minute test show "100% accuracy" in specificity and sensitivity, Bico says. The firm also acquired rights to the InstantConfirm Western-Blot confirmatory HIV rapid test and InstantDifferentiate rapid test for detecting the difference between HIV-1 and HIV-2. Bico plans initially to target overseas markets; GAIFAR will pursue FDA approval "immediately" for sales in the U.S